Global Oral Nonsteroidal Anti-Inflammatory Drugs Production, Demand and Key Producers, 2022-2028
Nonsteroidal anti-inflammatory drugs (NSAIDs) are medicines that are commonly used for pain relief, stress reduction and high temperature control. They are often used to relieve symptoms of periods of pain, sprains and strains, headaches, cold and flu, arthritis and other long-term pain causes. Non-steroidal medications have sedative and anti-inflammatory effects. Inflammation is caused by the COX-1 and COX-2 enzymes which are inhibited by non-steroidal anti-inflammatory medications (NSAIDs). Some common examples of typical non-steroidal anti-inflammatory medications include aspirin, naproxen, ibuprofen, and paracetamol.
This report studies the global Oral Nonsteroidal Anti-Inflammatory Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral Nonsteroidal Anti-Inflammatory Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Nonsteroidal Anti-Inflammatory Drugs that contribute to its increasing demand across many markets.
The global Oral Nonsteroidal Anti-Inflammatory Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Oral Nonsteroidal Anti-Inflammatory Drugs total production and demand, 2017-2028, (K Units)
Global Oral Nonsteroidal Anti-Inflammatory Drugs total production value, 2017-2028, (USD Million)
Global Oral Nonsteroidal Anti-Inflammatory Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Oral Nonsteroidal Anti-Inflammatory Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Oral Nonsteroidal Anti-Inflammatory Drugs domestic production, consumption, key domestic manufacturers and share
Global Oral Nonsteroidal Anti-Inflammatory Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Oral Nonsteroidal Anti-Inflammatory Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Oral Nonsteroidal Anti-Inflammatory Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Oral Nonsteroidal Anti-Inflammatory Drugs market based on the following parameters – headquarters, production locations, products portfolio, Oral Nonsteroidal Anti-Inflammatory Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Nonsteroidal Anti-Inflammatory Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Oral Nonsteroidal Anti-Inflammatory Drugs Market, By Region:
1. How big is the global Oral Nonsteroidal Anti-Inflammatory Drugs market?
2. What is the demand of the global Oral Nonsteroidal Anti-Inflammatory Drugs market?
3. What is the year over year growth of the global Oral Nonsteroidal Anti-Inflammatory Drugs market?
4. What is the production and production value of the global Oral Nonsteroidal Anti-Inflammatory Drugs market?
5. Who are the key producers in the global Oral Nonsteroidal Anti-Inflammatory Drugs market?
6. What are the growth factors driving the market demand?
This report studies the global Oral Nonsteroidal Anti-Inflammatory Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral Nonsteroidal Anti-Inflammatory Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Nonsteroidal Anti-Inflammatory Drugs that contribute to its increasing demand across many markets.
The global Oral Nonsteroidal Anti-Inflammatory Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Oral Nonsteroidal Anti-Inflammatory Drugs total production and demand, 2017-2028, (K Units)
Global Oral Nonsteroidal Anti-Inflammatory Drugs total production value, 2017-2028, (USD Million)
Global Oral Nonsteroidal Anti-Inflammatory Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Oral Nonsteroidal Anti-Inflammatory Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Oral Nonsteroidal Anti-Inflammatory Drugs domestic production, consumption, key domestic manufacturers and share
Global Oral Nonsteroidal Anti-Inflammatory Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Oral Nonsteroidal Anti-Inflammatory Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Oral Nonsteroidal Anti-Inflammatory Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Oral Nonsteroidal Anti-Inflammatory Drugs market based on the following parameters – headquarters, production locations, products portfolio, Oral Nonsteroidal Anti-Inflammatory Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Nonsteroidal Anti-Inflammatory Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Oral Nonsteroidal Anti-Inflammatory Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Penecillins
- Cephalosporins
- Tetracyclins
- Sulfonamides
- Other
- Sterilization
- Bacteriostasis
- Bayer AG
- Pfizer Inc
- Reckitt Benckiser Group PLC
- Novartis AG
- DAIICHI SANKYO COMPANY, LIMITED
- Zydus Group
- Lupin
- GSK Plc
- Glenmark Pharmaceuticals Inc
- Amneal Pharmaceuticals
- AstraZeneca
1. How big is the global Oral Nonsteroidal Anti-Inflammatory Drugs market?
2. What is the demand of the global Oral Nonsteroidal Anti-Inflammatory Drugs market?
3. What is the year over year growth of the global Oral Nonsteroidal Anti-Inflammatory Drugs market?
4. What is the production and production value of the global Oral Nonsteroidal Anti-Inflammatory Drugs market?
5. Who are the key producers in the global Oral Nonsteroidal Anti-Inflammatory Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Oral Nonsteroidal Anti-Inflammatory Drugs Introduction
1.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Supply & Forecast
1.2.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028)
1.2.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Pricing Trends (2017-2028)
1.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Region
1.3.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Region (2017-2028)
1.3.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Region (2017-2028)
1.3.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Region (2017-2028)
1.3.4 North America Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028)
1.3.5 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028)
1.3.6 China Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028)
1.3.7 Japan Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oral Nonsteroidal Anti-Inflammatory Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral Nonsteroidal Anti-Inflammatory Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Demand (2017-2028)
2.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption by Region
2.2.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption by Region (2017-2022)
2.2.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Forecast by Region (2023-2028)
2.3 United States Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.4 China Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.5 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.6 Japan Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.7 South Korea Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.8 ASEAN Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.9 India Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
3 WORLD ORAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Manufacturer (2017-2022)
3.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Manufacturer (2017-2022)
3.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Manufacturer (2017-2022)
3.4 Oral Nonsteroidal Anti-Inflammatory Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oral Nonsteroidal Anti-Inflammatory Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for Oral Nonsteroidal Anti-Inflammatory Drugs in 2021
3.6 Oral Nonsteroidal Anti-Inflammatory Drugs Market: Overall Company Footprint Analysis
3.6.1 Oral Nonsteroidal Anti-Inflammatory Drugs Market: Region Footprint
3.6.2 Oral Nonsteroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
3.6.3 Oral Nonsteroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Comparison
4.1.1 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Comparison
4.2.1 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Comparison
4.3.1 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Oral Nonsteroidal Anti-Inflammatory Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China Oral Nonsteroidal Anti-Inflammatory Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Penecillins
5.2.2 Cephalosporins
5.2.3 Tetracyclins
5.2.4 Sulfonamides
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Type (2017-2028)
5.3.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Type (2017-2028)
5.3.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Sterilization
6.2.2 Bacteriostasis
6.3 Market Segment by Application
6.3.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Application (2017-2028)
6.3.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Application (2017-2028)
6.3.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Bayer AG
7.1.1 Bayer AG Details
7.1.2 Bayer AG Major Business
7.1.3 Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.1.4 Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Bayer AG Recent Developments/Updates
7.1.6 Bayer AG Competitive Strengths & Weaknesses
7.2 Pfizer Inc
7.2.1 Pfizer Inc Details
7.2.2 Pfizer Inc Major Business
7.2.3 Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.2.4 Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Pfizer Inc Recent Developments/Updates
7.2.6 Pfizer Inc Competitive Strengths & Weaknesses
7.3 Reckitt Benckiser Group PLC
7.3.1 Reckitt Benckiser Group PLC Details
7.3.2 Reckitt Benckiser Group PLC Major Business
7.3.3 Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.3.4 Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Reckitt Benckiser Group PLC Recent Developments/Updates
7.3.6 Reckitt Benckiser Group PLC Competitive Strengths & Weaknesses
7.4 Novartis AG
7.4.1 Novartis AG Details
7.4.2 Novartis AG Major Business
7.4.3 Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.4.4 Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Novartis AG Recent Developments/Updates
7.4.6 Novartis AG Competitive Strengths & Weaknesses
7.5 DAIICHI SANKYO COMPANY, LIMITED
7.5.1 DAIICHI SANKYO COMPANY, LIMITED Details
7.5.2 DAIICHI SANKYO COMPANY, LIMITED Major Business
7.5.3 DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.5.4 DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 DAIICHI SANKYO COMPANY, LIMITED Recent Developments/Updates
7.5.6 DAIICHI SANKYO COMPANY, LIMITED Competitive Strengths & Weaknesses
7.6 Zydus Group
7.6.1 Zydus Group Details
7.6.2 Zydus Group Major Business
7.6.3 Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.6.4 Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Zydus Group Recent Developments/Updates
7.6.6 Zydus Group Competitive Strengths & Weaknesses
7.7 Lupin
7.7.1 Lupin Details
7.7.2 Lupin Major Business
7.7.3 Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.7.4 Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Lupin Recent Developments/Updates
7.7.6 Lupin Competitive Strengths & Weaknesses
7.8 GSK Plc
7.8.1 GSK Plc Details
7.8.2 GSK Plc Major Business
7.8.3 GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.8.4 GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 GSK Plc Recent Developments/Updates
7.8.6 GSK Plc Competitive Strengths & Weaknesses
7.9 Glenmark Pharmaceuticals Inc
7.9.1 Glenmark Pharmaceuticals Inc Details
7.9.2 Glenmark Pharmaceuticals Inc Major Business
7.9.3 Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.9.4 Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Glenmark Pharmaceuticals Inc Recent Developments/Updates
7.9.6 Glenmark Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.10 Amneal Pharmaceuticals
7.10.1 Amneal Pharmaceuticals Details
7.10.2 Amneal Pharmaceuticals Major Business
7.10.3 Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.10.4 Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Amneal Pharmaceuticals Recent Developments/Updates
7.10.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
7.11 AstraZeneca
7.11.1 AstraZeneca Details
7.11.2 AstraZeneca Major Business
7.11.3 AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.11.4 AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 AstraZeneca Recent Developments/Updates
7.11.6 AstraZeneca Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Oral Nonsteroidal Anti-Inflammatory Drugs and Key Manufacturers
8.2 Oral Nonsteroidal Anti-Inflammatory Drugs Manufacturing Costs
8.3 Oral Nonsteroidal Anti-Inflammatory Drugs Production Process
8.4 Oral Nonsteroidal Anti-Inflammatory Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Oral Nonsteroidal Anti-Inflammatory Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Oral Nonsteroidal Anti-Inflammatory Drugs Typical Distributors
9.3 Oral Nonsteroidal Anti-Inflammatory Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Oral Nonsteroidal Anti-Inflammatory Drugs Introduction
1.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Supply & Forecast
1.2.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028)
1.2.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Pricing Trends (2017-2028)
1.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Region
1.3.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Region (2017-2028)
1.3.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Region (2017-2028)
1.3.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Region (2017-2028)
1.3.4 North America Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028)
1.3.5 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028)
1.3.6 China Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028)
1.3.7 Japan Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oral Nonsteroidal Anti-Inflammatory Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral Nonsteroidal Anti-Inflammatory Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Demand (2017-2028)
2.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption by Region
2.2.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption by Region (2017-2022)
2.2.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Forecast by Region (2023-2028)
2.3 United States Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.4 China Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.5 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.6 Japan Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.7 South Korea Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.8 ASEAN Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
2.9 India Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028)
3 WORLD ORAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Manufacturer (2017-2022)
3.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Manufacturer (2017-2022)
3.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Manufacturer (2017-2022)
3.4 Oral Nonsteroidal Anti-Inflammatory Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oral Nonsteroidal Anti-Inflammatory Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for Oral Nonsteroidal Anti-Inflammatory Drugs in 2021
3.6 Oral Nonsteroidal Anti-Inflammatory Drugs Market: Overall Company Footprint Analysis
3.6.1 Oral Nonsteroidal Anti-Inflammatory Drugs Market: Region Footprint
3.6.2 Oral Nonsteroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
3.6.3 Oral Nonsteroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Comparison
4.1.1 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Comparison
4.2.1 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Comparison
4.3.1 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Oral Nonsteroidal Anti-Inflammatory Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China Oral Nonsteroidal Anti-Inflammatory Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Penecillins
5.2.2 Cephalosporins
5.2.3 Tetracyclins
5.2.4 Sulfonamides
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Type (2017-2028)
5.3.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Type (2017-2028)
5.3.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Sterilization
6.2.2 Bacteriostasis
6.3 Market Segment by Application
6.3.1 World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Application (2017-2028)
6.3.2 World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Application (2017-2028)
6.3.3 World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Bayer AG
7.1.1 Bayer AG Details
7.1.2 Bayer AG Major Business
7.1.3 Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.1.4 Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Bayer AG Recent Developments/Updates
7.1.6 Bayer AG Competitive Strengths & Weaknesses
7.2 Pfizer Inc
7.2.1 Pfizer Inc Details
7.2.2 Pfizer Inc Major Business
7.2.3 Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.2.4 Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Pfizer Inc Recent Developments/Updates
7.2.6 Pfizer Inc Competitive Strengths & Weaknesses
7.3 Reckitt Benckiser Group PLC
7.3.1 Reckitt Benckiser Group PLC Details
7.3.2 Reckitt Benckiser Group PLC Major Business
7.3.3 Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.3.4 Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Reckitt Benckiser Group PLC Recent Developments/Updates
7.3.6 Reckitt Benckiser Group PLC Competitive Strengths & Weaknesses
7.4 Novartis AG
7.4.1 Novartis AG Details
7.4.2 Novartis AG Major Business
7.4.3 Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.4.4 Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Novartis AG Recent Developments/Updates
7.4.6 Novartis AG Competitive Strengths & Weaknesses
7.5 DAIICHI SANKYO COMPANY, LIMITED
7.5.1 DAIICHI SANKYO COMPANY, LIMITED Details
7.5.2 DAIICHI SANKYO COMPANY, LIMITED Major Business
7.5.3 DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.5.4 DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 DAIICHI SANKYO COMPANY, LIMITED Recent Developments/Updates
7.5.6 DAIICHI SANKYO COMPANY, LIMITED Competitive Strengths & Weaknesses
7.6 Zydus Group
7.6.1 Zydus Group Details
7.6.2 Zydus Group Major Business
7.6.3 Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.6.4 Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Zydus Group Recent Developments/Updates
7.6.6 Zydus Group Competitive Strengths & Weaknesses
7.7 Lupin
7.7.1 Lupin Details
7.7.2 Lupin Major Business
7.7.3 Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.7.4 Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Lupin Recent Developments/Updates
7.7.6 Lupin Competitive Strengths & Weaknesses
7.8 GSK Plc
7.8.1 GSK Plc Details
7.8.2 GSK Plc Major Business
7.8.3 GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.8.4 GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 GSK Plc Recent Developments/Updates
7.8.6 GSK Plc Competitive Strengths & Weaknesses
7.9 Glenmark Pharmaceuticals Inc
7.9.1 Glenmark Pharmaceuticals Inc Details
7.9.2 Glenmark Pharmaceuticals Inc Major Business
7.9.3 Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.9.4 Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Glenmark Pharmaceuticals Inc Recent Developments/Updates
7.9.6 Glenmark Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.10 Amneal Pharmaceuticals
7.10.1 Amneal Pharmaceuticals Details
7.10.2 Amneal Pharmaceuticals Major Business
7.10.3 Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.10.4 Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Amneal Pharmaceuticals Recent Developments/Updates
7.10.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
7.11 AstraZeneca
7.11.1 AstraZeneca Details
7.11.2 AstraZeneca Major Business
7.11.3 AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
7.11.4 AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 AstraZeneca Recent Developments/Updates
7.11.6 AstraZeneca Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Oral Nonsteroidal Anti-Inflammatory Drugs and Key Manufacturers
8.2 Oral Nonsteroidal Anti-Inflammatory Drugs Manufacturing Costs
8.3 Oral Nonsteroidal Anti-Inflammatory Drugs Production Process
8.4 Oral Nonsteroidal Anti-Inflammatory Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Oral Nonsteroidal Anti-Inflammatory Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Oral Nonsteroidal Anti-Inflammatory Drugs Typical Distributors
9.3 Oral Nonsteroidal Anti-Inflammatory Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Region (2017-2022)
Table 5. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Region (2023-2028)
Table 6. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Region (2017-2022) & (K Units)
Table 7. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Region (2023-2028) & (K Units)
Table 8. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Region (2017-2022)
Table 9. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Region (2023-2028)
Table 10. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Oral Nonsteroidal Anti-Inflammatory Drugs Major Market Trends
Table 13. World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Oral Nonsteroidal Anti-Inflammatory Drugs Producers in 2021
Table 18. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Oral Nonsteroidal Anti-Inflammatory Drugs Producers in 2021
Table 20. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Oral Nonsteroidal Anti-Inflammatory Drugs Company Evaluation Quadrant
Table 22. World Oral Nonsteroidal Anti-Inflammatory Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Oral Nonsteroidal Anti-Inflammatory Drugs Production Site of Key Manufacturer
Table 24. Oral Nonsteroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
Table 25. Oral Nonsteroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
Table 26. Oral Nonsteroidal Anti-Inflammatory Drugs Competitive Factors
Table 27. Oral Nonsteroidal Anti-Inflammatory Drugs New Entrant and Capacity Expansion Plans
Table 28. Oral Nonsteroidal Anti-Inflammatory Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Oral Nonsteroidal Anti-Inflammatory Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Type (2017-2022) & (K Units)
Table 49. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Type (2023-2028) & (K Units)
Table 50. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Application (2017-2022) & (K Units)
Table 56. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Application (2023-2028) & (K Units)
Table 57. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 62. Bayer AG Major Business
Table 63. Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 64. Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Bayer AG Recent Developments/Updates
Table 66. Bayer AG Competitive Strengths & Weaknesses
Table 67. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Inc Major Business
Table 69. Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 70. Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Pfizer Inc Recent Developments/Updates
Table 72. Pfizer Inc Competitive Strengths & Weaknesses
Table 73. Reckitt Benckiser Group PLC Basic Information, Manufacturing Base and Competitors
Table 74. Reckitt Benckiser Group PLC Major Business
Table 75. Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 76. Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Reckitt Benckiser Group PLC Recent Developments/Updates
Table 78. Reckitt Benckiser Group PLC Competitive Strengths & Weaknesses
Table 79. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 80. Novartis AG Major Business
Table 81. Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 82. Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Novartis AG Recent Developments/Updates
Table 84. Novartis AG Competitive Strengths & Weaknesses
Table 85. DAIICHI SANKYO COMPANY, LIMITED Basic Information, Manufacturing Base and Competitors
Table 86. DAIICHI SANKYO COMPANY, LIMITED Major Business
Table 87. DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 88. DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. DAIICHI SANKYO COMPANY, LIMITED Recent Developments/Updates
Table 90. DAIICHI SANKYO COMPANY, LIMITED Competitive Strengths & Weaknesses
Table 91. Zydus Group Basic Information, Manufacturing Base and Competitors
Table 92. Zydus Group Major Business
Table 93. Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 94. Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Zydus Group Recent Developments/Updates
Table 96. Zydus Group Competitive Strengths & Weaknesses
Table 97. Lupin Basic Information, Manufacturing Base and Competitors
Table 98. Lupin Major Business
Table 99. Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 100. Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Lupin Recent Developments/Updates
Table 102. Lupin Competitive Strengths & Weaknesses
Table 103. GSK Plc Basic Information, Manufacturing Base and Competitors
Table 104. GSK Plc Major Business
Table 105. GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 106. GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. GSK Plc Recent Developments/Updates
Table 108. GSK Plc Competitive Strengths & Weaknesses
Table 109. Glenmark Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 110. Glenmark Pharmaceuticals Inc Major Business
Table 111. Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 112. Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Glenmark Pharmaceuticals Inc Recent Developments/Updates
Table 114. Glenmark Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 115. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Amneal Pharmaceuticals Major Business
Table 117. Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 118. Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Amneal Pharmaceuticals Recent Developments/Updates
Table 120. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 121. AstraZeneca Major Business
Table 122. AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 123. AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 124. Oral Nonsteroidal Anti-Inflammatory Drugs Raw Material
Table 125. Key Manufacturers of Oral Nonsteroidal Anti-Inflammatory Drugs Raw Materials
Table 126. Oral Nonsteroidal Anti-Inflammatory Drugs Typical Distributors
Table 127. Oral Nonsteroidal Anti-Inflammatory Drugs Typical Customers
Table 1. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Region (2017-2022)
Table 5. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Region (2023-2028)
Table 6. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Region (2017-2022) & (K Units)
Table 7. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Region (2023-2028) & (K Units)
Table 8. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Region (2017-2022)
Table 9. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Region (2023-2028)
Table 10. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Oral Nonsteroidal Anti-Inflammatory Drugs Major Market Trends
Table 13. World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Oral Nonsteroidal Anti-Inflammatory Drugs Producers in 2021
Table 18. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Oral Nonsteroidal Anti-Inflammatory Drugs Producers in 2021
Table 20. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Oral Nonsteroidal Anti-Inflammatory Drugs Company Evaluation Quadrant
Table 22. World Oral Nonsteroidal Anti-Inflammatory Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Oral Nonsteroidal Anti-Inflammatory Drugs Production Site of Key Manufacturer
Table 24. Oral Nonsteroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
Table 25. Oral Nonsteroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
Table 26. Oral Nonsteroidal Anti-Inflammatory Drugs Competitive Factors
Table 27. Oral Nonsteroidal Anti-Inflammatory Drugs New Entrant and Capacity Expansion Plans
Table 28. Oral Nonsteroidal Anti-Inflammatory Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Oral Nonsteroidal Anti-Inflammatory Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Oral Nonsteroidal Anti-Inflammatory Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Type (2017-2022) & (K Units)
Table 49. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Type (2023-2028) & (K Units)
Table 50. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Application (2017-2022) & (K Units)
Table 56. World Oral Nonsteroidal Anti-Inflammatory Drugs Production by Application (2023-2028) & (K Units)
Table 57. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 62. Bayer AG Major Business
Table 63. Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 64. Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Bayer AG Recent Developments/Updates
Table 66. Bayer AG Competitive Strengths & Weaknesses
Table 67. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Inc Major Business
Table 69. Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 70. Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Pfizer Inc Recent Developments/Updates
Table 72. Pfizer Inc Competitive Strengths & Weaknesses
Table 73. Reckitt Benckiser Group PLC Basic Information, Manufacturing Base and Competitors
Table 74. Reckitt Benckiser Group PLC Major Business
Table 75. Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 76. Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Reckitt Benckiser Group PLC Recent Developments/Updates
Table 78. Reckitt Benckiser Group PLC Competitive Strengths & Weaknesses
Table 79. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 80. Novartis AG Major Business
Table 81. Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 82. Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Novartis AG Recent Developments/Updates
Table 84. Novartis AG Competitive Strengths & Weaknesses
Table 85. DAIICHI SANKYO COMPANY, LIMITED Basic Information, Manufacturing Base and Competitors
Table 86. DAIICHI SANKYO COMPANY, LIMITED Major Business
Table 87. DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 88. DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. DAIICHI SANKYO COMPANY, LIMITED Recent Developments/Updates
Table 90. DAIICHI SANKYO COMPANY, LIMITED Competitive Strengths & Weaknesses
Table 91. Zydus Group Basic Information, Manufacturing Base and Competitors
Table 92. Zydus Group Major Business
Table 93. Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 94. Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Zydus Group Recent Developments/Updates
Table 96. Zydus Group Competitive Strengths & Weaknesses
Table 97. Lupin Basic Information, Manufacturing Base and Competitors
Table 98. Lupin Major Business
Table 99. Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 100. Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Lupin Recent Developments/Updates
Table 102. Lupin Competitive Strengths & Weaknesses
Table 103. GSK Plc Basic Information, Manufacturing Base and Competitors
Table 104. GSK Plc Major Business
Table 105. GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 106. GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. GSK Plc Recent Developments/Updates
Table 108. GSK Plc Competitive Strengths & Weaknesses
Table 109. Glenmark Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 110. Glenmark Pharmaceuticals Inc Major Business
Table 111. Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 112. Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Glenmark Pharmaceuticals Inc Recent Developments/Updates
Table 114. Glenmark Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 115. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Amneal Pharmaceuticals Major Business
Table 117. Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 118. Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Amneal Pharmaceuticals Recent Developments/Updates
Table 120. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 121. AstraZeneca Major Business
Table 122. AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Product and Services
Table 123. AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 124. Oral Nonsteroidal Anti-Inflammatory Drugs Raw Material
Table 125. Key Manufacturers of Oral Nonsteroidal Anti-Inflammatory Drugs Raw Materials
Table 126. Oral Nonsteroidal Anti-Inflammatory Drugs Typical Distributors
Table 127. Oral Nonsteroidal Anti-Inflammatory Drugs Typical Customers
LIST OF FIGURES
Figure 1. Oral Nonsteroidal Anti-Inflammatory Drugs Picture
Figure 2. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028) & (K Units)
Figure 5. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Region (2017-2028)
Figure 8. North America Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028) & (K Units)
Figure 9. Europe Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028) & (K Units)
Figure 10. China Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028) & (K Units)
Figure 11. Japan Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028) & (K Units)
Figure 12. Oral Nonsteroidal Anti-Inflammatory Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oral Nonsteroidal Anti-Inflammatory Drugs Demand (2017-2028) & (K Units)
Figure 15. World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 17. China Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 22. India Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Oral Nonsteroidal Anti-Inflammatory Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Nonsteroidal Anti-Inflammatory Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Nonsteroidal Anti-Inflammatory Drugs Markets in 2021
Figure 26. United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Oral Nonsteroidal Anti-Inflammatory Drugs in United States
Figure 30. Key Producers and Market Share of Oral Nonsteroidal Anti-Inflammatory Drugs in China
Figure 31. Key Producers and Market Share of Oral Nonsteroidal Anti-Inflammatory Drugs in Rest of World
Figure 32. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Type in 2021
Figure 34. Penecillins
Figure 35. Cephalosporins
Figure 36. Tetracyclins
Figure 37. Sulfonamides
Figure 38. Other
Figure 39. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Type (2017-2028)
Figure 40. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Type (2017-2028)
Figure 41. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Application in 2021
Figure 44. Sterilization
Figure 45. Bacteriostasis
Figure 46. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Application (2017-2028)
Figure 47. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Application (2017-2028)
Figure 48. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of Oral Nonsteroidal Anti-Inflammatory Drugs in 2021
Figure 50. Manufacturing Process Analysis of Oral Nonsteroidal Anti-Inflammatory Drugs
Figure 51. Oral Nonsteroidal Anti-Inflammatory Drugs Industrial Chain
Figure 52. Distribution Channel Breakdown for Oral Nonsteroidal Anti-Inflammatory Drugs Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Oral Nonsteroidal Anti-Inflammatory Drugs Picture
Figure 2. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028) & (K Units)
Figure 5. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Region (2017-2028)
Figure 8. North America Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028) & (K Units)
Figure 9. Europe Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028) & (K Units)
Figure 10. China Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028) & (K Units)
Figure 11. Japan Oral Nonsteroidal Anti-Inflammatory Drugs Production (2017-2028) & (K Units)
Figure 12. Oral Nonsteroidal Anti-Inflammatory Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oral Nonsteroidal Anti-Inflammatory Drugs Demand (2017-2028) & (K Units)
Figure 15. World Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 17. China Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 22. India Oral Nonsteroidal Anti-Inflammatory Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Oral Nonsteroidal Anti-Inflammatory Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Nonsteroidal Anti-Inflammatory Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Nonsteroidal Anti-Inflammatory Drugs Markets in 2021
Figure 26. United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Oral Nonsteroidal Anti-Inflammatory Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Oral Nonsteroidal Anti-Inflammatory Drugs in United States
Figure 30. Key Producers and Market Share of Oral Nonsteroidal Anti-Inflammatory Drugs in China
Figure 31. Key Producers and Market Share of Oral Nonsteroidal Anti-Inflammatory Drugs in Rest of World
Figure 32. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Type in 2021
Figure 34. Penecillins
Figure 35. Cephalosporins
Figure 36. Tetracyclins
Figure 37. Sulfonamides
Figure 38. Other
Figure 39. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Type (2017-2028)
Figure 40. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Type (2017-2028)
Figure 41. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Application in 2021
Figure 44. Sterilization
Figure 45. Bacteriostasis
Figure 46. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Market Share by Application (2017-2028)
Figure 47. World Oral Nonsteroidal Anti-Inflammatory Drugs Production Value Market Share by Application (2017-2028)
Figure 48. World Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of Oral Nonsteroidal Anti-Inflammatory Drugs in 2021
Figure 50. Manufacturing Process Analysis of Oral Nonsteroidal Anti-Inflammatory Drugs
Figure 51. Oral Nonsteroidal Anti-Inflammatory Drugs Industrial Chain
Figure 52. Distribution Channel Breakdown for Oral Nonsteroidal Anti-Inflammatory Drugs Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
